This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Intellectual Property

Apr. 17, 2013

Anthony M. Insogna

Jones Day San Diego Pharmaceuticals


As the regulatory landscape shifts, Insogna said that he keeps his eyes open for potential opportunities for his clients.


One example is the way the Food and Drug Administration is evaluating drugs these days.


"That is important for us," he said. "They are requiring drugs to have companion diagnostics to improve their efficacy or select patent populations with the highest benefit. I have been, and continue to look at patent opportunities ...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up